These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 8640617

  • 21. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC.
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [Abstract] [Full Text] [Related]

  • 22. Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis.
    Martins EB, Fleming KA, Garrido MC, Hine KR, Chapman RW.
    Gastroenterology; 1994 Aug; 107(2):537-42. PubMed ID: 8039630
    [Abstract] [Full Text] [Related]

  • 23. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.
    Layfield LJ, Cramer H.
    Diagn Cytopathol; 2005 Feb; 32(2):119-24. PubMed ID: 15637668
    [Abstract] [Full Text] [Related]

  • 24. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Ahrendt SA, Eisenberger CF, Yip L, Rashid A, Chow JT, Pitt HA, Sidransky D.
    J Surg Res; 1999 Jun 01; 84(1):88-93. PubMed ID: 10334895
    [Abstract] [Full Text] [Related]

  • 25. What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?
    Kano Y, Ishikawa T, Yamao K, Mizutani Y, Iida T, Uetsuki K, Yamamura T, Furukawa K, Nakamura M, Kawashima H.
    J Gastroenterol; 2024 Jul 01; 59(7):621-628. PubMed ID: 38713262
    [Abstract] [Full Text] [Related]

  • 26. A case of intrahepatic cholangiocarcinoma associated with primary sclerosing cholangitis.
    Kanemitsu E, Esaki M.
    Jpn J Clin Oncol; 2010 Jun 01; 40(6):600. PubMed ID: 20508074
    [No Abstract] [Full Text] [Related]

  • 27. [27-year-old patient with asymptomatic cholestasis and liver tumor].
    Möllers M, Gladisch R, Heine M, Georgi M, Heene DL.
    Internist (Berl); 1996 Sep 01; 37(9):931-5. PubMed ID: 8964688
    [No Abstract] [Full Text] [Related]

  • 28. Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma.
    Lee KB.
    Clin Mol Hepatol; 2016 Sep 01; 22(3):400-405. PubMed ID: 27729636
    [Abstract] [Full Text] [Related]

  • 29. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.
    Linder S, Söderlund C.
    Hepatogastroenterology; 2001 Sep 01; 48(38):387-92. PubMed ID: 11379315
    [Abstract] [Full Text] [Related]

  • 30. Intrahepatic segmental primary sclerosing cholangitis: report of a case.
    Matsumoto T, Ajiki T, Matsumoto I, Tominaga M, Hori H, Mita Y, Fujita T, Fujino Y, Suzuki Y, Ku Y, Kuroda Y.
    Surg Today; 2006 Sep 01; 36(7):638-41. PubMed ID: 16794801
    [Abstract] [Full Text] [Related]

  • 31. Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP.
    Azeem N, Gostout CJ, Knipschield M, Baron TH.
    Gastrointest Endosc; 2014 May 01; 79(5):773-779.e2. PubMed ID: 24206748
    [Abstract] [Full Text] [Related]

  • 32. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
    Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ.
    Am J Gastroenterol; 2000 Jan 01; 95(1):204-7. PubMed ID: 10638584
    [Abstract] [Full Text] [Related]

  • 33. Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography.
    Vitellas KM, Keogan MT, Freed KS, Enns RA, Spritzer CE, Baillie JM, Nelson RC.
    Radiographics; 2000 Jan 01; 20(4):959-75; quiz 1108-9, 1112. PubMed ID: 10903686
    [Abstract] [Full Text] [Related]

  • 34. Hepatic hilar inflammatory pseudotumor mimicking cholangiocarcinoma with cholangitis and phlebitis--a variant of primary sclerosing cholangitis?
    Nonomura A, Minato H, Shimizu K, Kadoya M, Matsui O.
    Pathol Res Pract; 1997 Jan 01; 193(7):519-25; discussion 526. PubMed ID: 9342759
    [Abstract] [Full Text] [Related]

  • 35. Role of biliary brush cytology in primary sclerosing cholangitis.
    Lal A, Okonkwo A, Schindler S, De Frias D, Nayar R.
    Acta Cytol; 2004 Jan 01; 48(1):9-12. PubMed ID: 14969174
    [Abstract] [Full Text] [Related]

  • 36. Value of brush border cytology for dominant strictures in primary sclerosing cholangitis.
    Stiehl A.
    Endoscopy; 1999 May 01; 31(4):333-4. PubMed ID: 10376464
    [No Abstract] [Full Text] [Related]

  • 37. Proliferative index facilitates distinction between benign biliary lesions and intrahepatic cholangiocarcinoma.
    Tsokos CG, Krings G, Yilmaz F, Ferrell LD, Gill RM.
    Hum Pathol; 2016 Nov 01; 57():61-67. PubMed ID: 27396933
    [Abstract] [Full Text] [Related]

  • 38. A localized primary sclerosing cholangitis preoperatively diagnosed as hilar cholangiocarcinoma; report of a case.
    Kojima T, Shimura T, Takahashi M, Haga N, Hashimoto S, Fukuda T, Kuwano H.
    Hepatogastroenterology; 2004 Nov 01; 51(58):961-3. PubMed ID: 15239224
    [Abstract] [Full Text] [Related]

  • 39. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB, Jacobson IM.
    Rev Gastroenterol Disord; 2009 Nov 01; 9(2):E41-7. PubMed ID: 19668124
    [Abstract] [Full Text] [Related]

  • 40. The evaluation of MSX2 mRNA expression level in biliary brush cytological specimens.
    Ito H, Satoh K, Hamada S, Hirota M, Kanno A, Ishida K, Unno J, Masamune A, Katayose Y, Unno M, Shimosegawa T.
    Anticancer Res; 2011 Mar 01; 31(3):1011-7. PubMed ID: 21498730
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.